glp-1 agonists vision loss blindness Do Medications Cause Eye Problems? Understanding the NAION Risk – Revolution Health & Wellness Researchers Find Small Increased Risk
Description
Factors such as rapid weight reduction, caloric restriction, nutritional deficiencies, and metabolic changes all play contributory roles
Perkovic, V
This overlap highlights their promise as pharmacological analogues of exercise, and underscores the need for biomarker-driven, disease-specific trials to establish whether GLP-1RAs can deliver durable disease modification across the spectrum of neurodegenerative diseases
BenjafieldAVAyasNTEastwoodPRHeinzerRIpMSMMorrellMJet al
Overeating was a cue, weight was a symptom, a signal that we needed to pay attention
